Delivery Order SPE2DB20D3104-SPE2DB25FV9M7
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,227.54 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This firm fixed-price, competitively awarded contract with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be performed from the contractor's location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency awarded a delivery order valued at $3,631.68 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count packages) on September 4, 2025, with an ultimate completion date of September 5, 2025. This competitive award, issued under firm fixed-price terms with no set-aside designation, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal medical procurement. The contract will be performed at...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on August 25, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $3,863.83. The award represents a firm fixed-price delivery order with an ultimate completion date of August 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This is a non-set-aside contract awarded through competitive procedures,...
- The Defense Logistics Agency awarded a delivery order valued at $1,410.00 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $2,526.92. This non-competitive delivery order represents a firm fixed-price transaction with an ultimate completion date of August 21, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award leverages AmerisourceBergen's existing relationship with the DLA...
- The Defense Logistics Agency awarded a $3,013.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-set-aside delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office division, with performance to occur at the company's headquarters in...
- The Defense Logistics Agency awarded a delivery order valued at $1,102.78 to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on September 17, 2025, with an ultimate completion date of September 18, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The contract will be performed at AmerisourceBergen Drug Corp's corporate office location in Conshohocken, Pennsylvania, which serves as the...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,129.30 for Mucinex D ER 600-60 mg tablets (18-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's existing DLA Troop Support Medical Indefinite Delivery Contract (IDC SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,877.76 to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 600-60 mg tablets (18-count units). The contract was awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, and is structured as a firm fixed price delivery order with no set-aside designation. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 22, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,219.54. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for ultimate completion by August 25, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken,...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9M7Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,509.56. This competitive, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery/Indefinite Quantity (IDIQ) contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies a comprehensive range of pharmaceuticals and medical supplies to support military healthcare systems and other federal agencies. The company's extensive portfolio of federal awards demonstrates its capability to fulfill diverse medical supply needs through competitive procurement processes, supporting defense health initiatives and military readiness requirements across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 8/13/25 |